PROUD Study - Preventing Opioid Use Disorders
Public ClinicalTrials.gov record NCT04766996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04766996
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Emory University
- Other
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Interventions
- Ancef Drug
- Baby aspirin Drug
- Bupivacaine hydrochloride Drug
- Decadron Drug
- Guided mindfulness exercises Behavioral
- Lidocaine Drug
- Meloxicam Drug
- Pepcid Drug
- Prednisone Drug
- Pregabalin Drug
- Prilosec Drug
- Propofol Drug
- Reglan Drug
- Self-administered aromatherapy Other
- Toradol Drug
- Tramadol Drug
- Tranexamic Acid (TXA) Drug
- Tylenol/Acetaminophen Drug
- Versed Drug
- Voltaren Drug
- Zofran Drug
Drug · Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 16, 2021
- Primary completion
- Dec 26, 2021
- Completion
- Dec 26, 2021
- Last update posted
- Jun 21, 2023
2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University Orthopaedic and Spine Hospital | Atlanta | Georgia | 30322 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04766996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04766996 live on ClinicalTrials.gov.